Manganese (Mn) is a potent neurotoxin. We hypothesize that PARK2, a strong Parkinson's disease (PD) genetic risk factor, alters neuronal vulnerability to modifiers of cellular Mn status, particularly at the level of mitochondrial dysfunction and oxidative stress. The long-term goal of this research is to elucidate the basis of Mn-induced neurotoxicity and to identify mechanistic-based neuroprotective strategies to mitigate human Mn exposure risk. Our approach will utilize a novel high-throughput assay of intracellular Mn levels to identify small molecule modifiers of cellular Mn status and neurotoxicity. Genetic modifiers of Mn transport and toxicity will be defined and translational studies of existing and newly identified genetic and small molecule modifiers of Mn toxicity will be performed utilizing a primary human neuronal model system based upon human induced pluripotent stem cell (hiPSC) technology.
Aim 1 will identify lead compounds that alter neuronal Mn transport and toxicity in vitro using striatal and mesencephalic murine neuronal cell lines and in vivo using C. elegans.
Aim 2 will delineate functional pathways that regulate Mn transport and toxicity in vivo and in vitro.
Specific Aim 3 will test the hypothesis that human neuronal models of PD exhibit increased sensitivity to perturbations of cellular Mn status.
These specific aims hold the promise of delineating common initiator signals for the modulation of Mn neurotoxicity, shedding light on mechanisms and susceptibility associated with exposure to this metal. This dual-PI proposal is bolstered by its use of innovative state-of-the-art complimentary approaches in diverse model systems.
The proposed studies will (1) provide novel and innovative information on functional and hierarchal relationships between small molecule modifiers of cellular manganese (Mn) status and Mn neurotoxicity, (2) identify novel therapeutic modalities for Mn-induced neurotoxicity, and (3) delineate gene-environment interactions within and across species in the integrated systems response to Mn. Our multidisciplinary approach seeks to define the functional domains that regulate key nodes of interaction between Mn and biological systems and the role genetic traits of susceptibility play in mediating molecular mechanisms of neurological disease influence by Mn exposure.
|Ke, Tao; Gonçalves, Filipe Marques; Gonçalves, Cinara Ludvig et al. (2018) Post-translational modifications in MeHg-induced neurotoxicity. Biochim Biophys Acta Mol Basis Dis :|
|Rohn, Isabelle; Marschall, Talke Anu; Kroepfl, Nina et al. (2018) Selenium species-dependent toxicity, bioavailability and metabolic transformations in Caenorhabditis elegans. Metallomics 10:818-827|
|Johnson Jr, James; Pajarillo, Edward Alain B; Taka, Equar et al. (2018) Valproate and sodium butyrate attenuate manganese-decreased locomotor activity and astrocytic glutamate transporters expression in mice. Neurotoxicology 64:230-239|
|Casjens, Swaantje; Dydak, Urike; Dharmadhikari, Shalmali et al. (2018) Association of exposure to manganese and iron with striatal and thalamic GABA and other neurometabolites - Neuroimaging results from the WELDOX II study. Neurotoxicology 64:60-67|
|Pinkas, Adi; Cunha Martins Jr, Airton; Aschner, Michael (2018) C. elegans-An Emerging Model to Study Metal-Induced RAGE-Related Pathologies. Int J Environ Res Public Health 15:|
|Unoki, Takamitsu; Akiyama, Masahiro; Kumagai, Yoshito et al. (2018) Molecular Pathways Associated With Methylmercury-Induced Nrf2 Modulation. Front Genet 9:373|
|Bryan, Miles R; Uhouse, Michael A; Nordham, Kristen D et al. (2018) Phosphatidylinositol 3 kinase (PI3K) modulates manganese homeostasis and manganese-induced cell signaling in a murine striatal cell line. Neurotoxicology 64:185-194|
|Wu, Shenshen; Meng, Qingtao; Zhang, Chengcheng et al. (2018) DR4 mediates the progression, invasion, metastasis and survival of colorectal cancer through the Sp1/NF1 switch axis on genomic locus. Int J Cancer 143:289-297|
|da Silveira, Tássia Limana; Zamberlan, Daniele Coradine; Arantes, Leticia Priscilla et al. (2018) Quinolinic acid and glutamatergic neurodegeneration in Caenorhabditis elegans. Neurotoxicology 67:94-101|
|Ruszkiewicz, Joanna A; Pinkas, Adi; Miah, Mahfuzur R et al. (2018) C. elegans as a model in developmental neurotoxicology. Toxicol Appl Pharmacol 354:126-135|
Showing the most recent 10 out of 199 publications